Sorafenib remains standard therapy for advanced hepatocellular carcinoma

Sorafenib should remain standard therapy for patients with advanced hepatocellular carcinoma, following the negative results of the SEARCH clinical trial, researchers believe.

Liver cancer: standard treatment for hepatocellular carcinoma unchanged (photo: SPL)
Liver cancer: standard treatment for hepatocellular carcinoma unchanged (photo: SPL)

The SEARCH trial looked at 720 patients who were randomised 1:1 to receive either erlotinib and sorafenib or sorafenib plus placebo.

The primary endpoint of the phase III  randomised, double-blind, placebo-controlled trial was a 33% increase in the overall survival on the combination treatment in comparison to sorafenib/placebo.

Personalised medicines, access to cancer drugs and to palliative care are the main issues faced by oncology patients and their healthcare professionals in Europe and worldwide, according to the organisers of the 2012 meeting of the European Society of Medical Oncology.

According to a study from Oxford University annual healthcare costs per head of population for cancer range from 32 to 165 euros across EU countries.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

GP dilemma: What should I do if a parent sends their child with COVID-19 symptoms to school?

GP dilemma: What should I do if a parent sends their child with COVID-19 symptoms to school?

Medical Protection's Dr Clare Devlin offers advice on how GPs should respond to parents...

GPs risk missing out on vital COVID-19 risk assessments, BMA warns

GPs risk missing out on vital COVID-19 risk assessments, BMA warns

GPs risk missing out on COVID-19 risk assessments unless practices are guaranteed...

GPs call for partial suspension of network DES amid heavy workload

GPs call for partial suspension of network DES amid heavy workload

GPs leading primary care networks (PCNs) have called for the partial suspension of...

UK COVID-19 alert level raised as GPs prioritised for testing

UK COVID-19 alert level raised as GPs prioritised for testing

The government has raised the UK's COVID-19 alert level to four amid reports that...

UK on course for 50,000 COVID-19 cases a day by mid-October

UK on course for 50,000 COVID-19 cases a day by mid-October

The UK could see 50,000 COVID-19 cases per day by mid-October, with the epidemic...

Stricter short-term COVID-19 measures needed to avoid second national lockdown, BMA warns

Stricter short-term COVID-19 measures needed to avoid second national lockdown, BMA warns

COVID-19 infection rates will ‘soar’ and the NHS will ‘once again be crippled’ if...